Literature DB >> 2248536

Effects of newborn screening of cystic fibrosis on reported maternal behaviour.

C Boland1, N L Thompson.   

Abstract

Screening for cystic fibrosis is highly controversial. Concerns have been expressed that newborn screening may cause mothers, who had considered their child to be healthy before diagnosis, to overprotect their child. Some critics of screening also suggest that a period of delay from onset of symptoms to diagnosis may help a mother adjust to the reality of the child's lethal condition. This study compared the strength of overprotective child rearing attitudes of 29 mothers whose children were screened (13 had symptomatic children and 16 asymptomatic children) with the attitudes of 29 mothers whose children were diagnosed after the onset of symptoms. Results indicate that newborn screening had not increased a mother's tendency to overprotect her child with cystic fibrosis and in some cases the tendency had decreased. Further, delay in diagnosis when screening was not conducted usually caused mothers considerable personal distress.

Entities:  

Mesh:

Year:  1990        PMID: 2248536      PMCID: PMC1792618          DOI: 10.1136/adc.65.11.1240

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Development of a parental attitude research instrument.

Authors:  E S SCHAEFER; R Q BELL
Journal:  Child Dev       Date:  1958-09

2.  Editorial: The risks of screening.

Authors:  A J Solnit
Journal:  Pediatrics       Date:  1976-05       Impact factor: 7.124

3.  Routine screening of newborns for cystic fibrosis: not yet.

Authors:  N A Holtzman
Journal:  Pediatrics       Date:  1984-01       Impact factor: 7.124

4.  Early diagnosis of cystic fibrosis: to screen or not to screen--an important question.

Authors:  P M Farrell
Journal:  Pediatrics       Date:  1984-01       Impact factor: 7.124

5.  Hepatic cellular injury during varicella.

Authors:  M G Myers
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

6.  Diagnostic delay in Duchenne s muscular dystrophy and cystic fibrosis.

Authors:  B J Rosenstein; T S Langbaum
Journal:  JAMA       Date:  1982-06-25       Impact factor: 56.272

7.  Why we should not screen our newborns for cystic fibrosis.

Authors:  R Gitzelmann
Journal:  Helv Paediatr Acta       Date:  1981

8.  Screening for cystic fibrosis.

Authors:  J A Dodge; H C Ryley
Journal:  Arch Dis Child       Date:  1982-10       Impact factor: 3.791

9.  Overdiagnosis of cystic fibrosis.

Authors:  T J David; B M Phillips
Journal:  Lancet       Date:  1982-11-27       Impact factor: 79.321

10.  Diagnostic delay in cystic fibrosis: lessons from newborn screening.

Authors:  B Wilcken; S J Towns; C M Mellis
Journal:  Arch Dis Child       Date:  1983-11       Impact factor: 3.791

View more
  4 in total

Review 1.  Early and late outcome of cystic fibrosis screening.

Authors:  M R Green; L T Weaver
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

2.  Clinical outcomes of newborn screening for cystic fibrosis.

Authors:  D L Waters; B Wilcken; L Irwing; P Van Asperen; C Mellis; J M Simpson; J Brown; K J Gaskin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

3.  Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period.

Authors:  L T Weaver; M R Green; K Nicholson; J Mills; M E Heeley; J A Kuzemko; S Austin; G A Gregory; A E Dux; J A Davis
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

4.  Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.

Authors:  E Ranieri; B D Lewis; R L Gerace; R G Ryall; C P Morris; P V Nelson; W F Carey; E F Robertson
Journal:  BMJ       Date:  1994-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.